艾普拉唑治疗胃溃疡的临床效果及对胃黏膜状态的影响
2025-08-09林蜊敏
ClinicalEffectand InfluenceforGastric Mucosal StateofIlaprazoleintheTreatmentofPatients with GastricUlcer/LINLimin.//Medical InnovationofChina,2025,22(16):030-034
[Abstract]Objective:To investigate theclinical efectand influence for gastricmucosal stateof Iaprazole inthetreatmentof patientswith gastric ulcer.Method:Atotalof 8O patients with gastriculcerinLongyanPeople's Hospital from January 2O23 to June 2O24 were divided into groups bythe methodofrandom number table method. The two groups were treated with Bismuth Pectin,Amoxicilln and Clarithromycin,then 40 patients of control group were treated with Omeprazole,40 cases of observation group were treated with Iaprazole.Thenthe total effective ratesforgastric ulcer,adverse reactions rates,gastrointestinal hormones [gastrin(GAS)and motilin (MTL)] and gastric mucosal state [percentages of epidermal growth factor receptor (EGFR)and basic fibroblast growth factor (bFGF)positive cells and gastric mucosal morphology score] before and afterthe treatment of two groups were compared.Result:The total effectiverates for gastriculcerof observation group was significantly higherthanthat of control group,the total rate of various adverse reactions was significantly lower than that of control group,the differences were statistically significant ( P lt;0.05), the levels of gastrointestinal hormones,percentages of EGFR, bFGF positive cells and gastric mucosal morphology scores of two groups before the treatment were compared,the differenceswere not statistically significant ( Pgt; 0.05),the levels of gastrointestinal hormones and gastric mucosal morphology scores of observation group after the treatment were significantly lower than those of control group, percentages of EGFR,bFGF positive cels were significantly higher than those of control group,thelevels of the gastrointestinal hormones and gastric mucosal morphology scores of two groups were significantly lower than those beforethetreatment,and percentages ofEGFR,bFGFpositive cels were significantly higherthan those within group before he treatment, the diferences were statistically significant (P
胃溃疡是消化系统常见病之一,患者的胃部疼痛不适、食欲不振等情况表现突出,对患者的消化系统及其他方面造成较大不良影响。与胃溃疡相关的研究显示,本病患者的胃黏膜损伤明显,胃肠动力相对失衡,胃肠激素受之影响应激性升高,而对其表达失衡的改善程度是疾病治疗效果的重要参考项目[1-2]。再者,本病患者的胃黏膜受损情况相对突出,而在损伤及修复过程中,胃黏膜生长因子及胃黏膜形态等方面均相对异常,对其进行细致监测与评估的价值较高。临床中采用艾普拉唑治疗胃溃疡的研究不断增多[3-5],但是效果的细致研究不足,对上述胃黏膜状态方面的改善效果研究更为匮乏。故本研究探究艾普拉唑在胃溃疡患者中的疗效、安全性及对胃黏膜状态的影响,并报道如下。
1资料与方法
1.1一般资料
将2023年1月一2024年6月的80例胃溃疡患者根据随机数字表法分为对照组与观察组,每组40例。纳入标准:20岁及以上;诊治的胃溃疡。排除标准:多发性溃疡;合并消化系统出血及其他消化系统疾病;合并恶性肿瘤;沟通或认知障碍;合并高血压、慢阻肺、糖尿病等疾病;1个月内接受相关治疗;妊娠、哺乳等特殊阶段;合并穿孔。本次研究经医学伦理学委员会批准。患者知情本研究,且签署本研究的同意书。
1.2 方法
两组患者均禁忌生冷辛辣饮食,均服用胶体果胶铋胶囊「生产厂家:上海再迪郸城制药有限公司,批准文号:国药准字H19983171,规格: 50mg (以铋计) ]150mg/ 次,餐前……
